AddLife AB (publ) (LON:0REZ)

Market Cap	1.80B
Revenue (ttm)	801.48M
Net Income (ttm)	25.87M
Shares Out	n/a
EPS (ttm)	0.21
PE Ratio	69.75
Forward PE	31.13
Dividend	0.06 (0.03%)
Ex-Dividend Date	May 9, 2025

Volume	2,758
Average Volume	1,988
Open	193.30
Previous Close	191.01
Day's Range	193.30 - 195.00
52-Week Range	126.90 - 199.40
Beta	1.55
RSI	64.86
Earnings Date	Oct 23, 2025

About AddLife AB

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis equipment. It offers products and solutions, including instruments and equipment, plastic consumables, cell biology, reagents, general ...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1906
• Employees: 2,181
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0REZ

Financial Performance

In 2024, AddLife AB's revenue was 10.29 billion, an increase of 6.21% compared to the previous year's 9.69 billion. Earnings were 252.00 million, an increase of 32.63%.

Financial numbers in SEK